Terms: = Pancreatic cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun
325 results:
1. Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer.
Yang H; Cheng J; Zhuang H; Xu H; Wang Y; Zhang T; Yang Y; Qian H; Lu Y; Han F; Cao L; Yang N; Liu R; Yang X; Zhang J; Wu J; Zhang N
Cancer Cell; 2024 Apr; 42(4):535-551.e8. PubMed ID: 38593780
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of ATM promotes PD-L1 expression by activating JNK/c-jun/TNF-α signaling axis in triple-negative breast cancer.
Liu C; Qian X; Yu C; Xia X; Li J; Li Y; Xie Y; Gao G; Song Y; Zhang M; Xue H; Wang X; Sun H; Liu J; Deng W; Guo X
Cancer Lett; 2024 Apr; 586():216642. PubMed ID: 38278470
[TBL] [Abstract] [Full Text] [Related]
3. Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression.
Bhattacharyya S; Oon C; Diaz L; Sandborg H; Stempinski ES; Saoi M; Morgan TK; López CS; Cross JR; Sherman MH
Nat Cancer; 2024 Feb; 5(2):283-298. PubMed ID: 38195933
[TBL] [Abstract] [Full Text] [Related]
4. Challenge in optimizing robotic pancreaticoduodenectomy including nerve plexus hanging maneuver: a Japanese single center experience of 76 cases.
Mizumoto T; Takahara T; Nishimura A; Mii S; Uchida Y; Iwama H; Kojima M; Kato Y; Uyama I; Suda K
Surg Endosc; 2024 Feb; 38(2):1077-1087. PubMed ID: 38168732
[TBL] [Abstract] [Full Text] [Related]
5. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis.
Fan W; Cao D; Yang B; Wang J; Li X; Kitka D; Li TWH; You S; Shiao S; Gangi A; Posadas E; Di Vizio D; Tomasi ML; Seki E; Mato JM; Yang H; Lu SC
J Hepatol; 2024 Mar; 80(3):443-453. PubMed ID: 38086446
[TBL] [Abstract] [Full Text] [Related]
6. Current status of Complementary and Alternative Medicine Interventions in the Management of pancreatic cancer - An Overview.
Tarasiuk A; Mirocha G; Fichna J
Curr Treat Options Oncol; 2023 Dec; 24(12):1852-1869. PubMed ID: 38079061
[TBL] [Abstract] [Full Text] [Related]
7. TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma.
Zhou Y; Jin J; Ji Y; Zhang J; Fu N; Chen M; Wang J; Qin K; Jiang Y; Cheng D; Deng X; Shen B
J Transl Med; 2023 Dec; 21(1):872. PubMed ID: 38037073
[TBL] [Abstract] [Full Text] [Related]
8. Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8
He W; Wang X; Chen M; Li C; Chen W; Pan L; Cui Y; Yu Z; Wu G; Yang Y; Xu M; Dong Z; Ma K; Wang J; He Z
Clin Transl Med; 2023 Nov; 13(11):e1465. PubMed ID: 37997519
[TBL] [Abstract] [Full Text] [Related]
9. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-ap1 axis.
Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
[TBL] [Abstract] [Full Text] [Related]
10. Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk.
Qin H; Chen J; Bouchekioua-Bouzaghou K; Meng YM; Griera JB; Jiang X; Kong X; Wang M; Xu Q; Wong PP
J Transl Med; 2023 Oct; 21(1):702. PubMed ID: 37814317
[TBL] [Abstract] [Full Text] [Related]
11. Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma.
Karatug Kacar A
Chem Biol Drug Des; 2024 Jan; 103(1):e14368. PubMed ID: 37802653
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes.
Li Q; Liu H; Jin Y; Yu Y; Wang Y; Wu D; Guo Y; Xi L; Ye D; Pan Y; Zhang X; Li J
Comput Biol Med; 2023 Oct; 165():107370. PubMed ID: 37643511
[TBL] [Abstract] [Full Text] [Related]
13. Protein Advanced Glycation End Products and Their Implications in pancreatic cancer.
Senavirathna L; Pan S; Chen R
Cancer Prev Res (Phila); 2023 Nov; 16(11):601-610. PubMed ID: 37578815
[TBL] [Abstract] [Full Text] [Related]
14. TMPOP2 Inhibition Suppresses pancreatic cancer Cell Migration and Development by Repressing The JNK/STAT3 Pathway.
Liang J; Cao H; Wang G; Wei L; Dong L; Chen G; Li Q; Zhu D
Adv Biol (Weinh); 2023 Dec; 7(12):e2300113. PubMed ID: 37469237
[TBL] [Abstract] [Full Text] [Related]
15. Similarity of oncogenic protein expression in KRAS
Tanaka Y; Kamimura K; Shibata O; Ogawa K; Oda C; Abe H; Ikarashi S; Hayashi K; Yokoo T; Wakai T; Terai S
Biochem Biophys Res Commun; 2023 Sep; 673():29-35. PubMed ID: 37356142
[TBL] [Abstract] [Full Text] [Related]
16. Association of soft drinks and 100% fruit juice consumption with risk of cancer: a systematic review and dose-response meta-analysis of prospective cohort studies.
Pan B; Lai H; Ma N; Li D; Deng X; Wang X; Zhang Q; Yang Q; Wang Q; Zhu H; Li M; Cao X; Tian J; Ge L; Yang K
Int J Behav Nutr Phys Act; 2023 May; 20(1):58. PubMed ID: 37189146
[TBL] [Abstract] [Full Text] [Related]
17. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/Yap1/c-jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
18. Ral GTPase promotes metastasis of pancreatic ductal adenocarcinoma via elevation of TGF-β1 production.
Cao M; Li X; Trinh DA; Yoshimachi S; Goto K; Sakata N; Ishida M; Ohtsuka H; Unno M; Wang Y; Shirakawa R; Horiuchi H
J Biol Chem; 2023 Jun; 299(6):104754. PubMed ID: 37116704
[TBL] [Abstract] [Full Text] [Related]
19. Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer.
Hamdan FH; Abdelrahman AM; Kutschat AP; Wang X; Ekstrom TL; Jalan-Sakrikar N; Wegner Wippel C; Taheri N; Tamon L; Kopp W; Aggrey-Fynn J; Bhagwate AV; Alva-Ruiz R; Lynch I; Yonkus J; Kosinsky RL; Gaedcke J; Hahn SA; Siveke JT; Graham R; Najafova Z; Hessmann E; Truty MJ; Johnsen SA
Gut; 2023 Jun; 72(6):1174-1185. PubMed ID: 36889906
[TBL] [Abstract] [Full Text] [Related]
20. Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer.
Ervin EH; French R; Chang CH; Pauklin S
Semin Cancer Biol; 2022 Dec; 87():48-83. PubMed ID: 36347438
[TBL] [Abstract] [Full Text] [Related]
[Next]
